Dr. H. Richard Alexander, Jr.
Georgetown University School of Medicine, Washington, DC
National Naval Medical Center, Bethesda, MD
Memorial Sloan Kettering Cancer Center, New York, NY
Dr. H. Richard Alexander, Jr., a world-renowned surgical oncologist and researcher, is professor and associate chairman for clinical research at the University of Maryland in the Department of Surgery. Additionally, Dr. Alexander is actively involved in the clinical treatment of cancer patients at the University of Maryland Marlene and Stewart Greenebaum Cancer Center. Prior to assuming his current posts at the University of Maryland, Dr. Alexander was employed by the National Institutes of Health serving in several roles over the course of 16 years, including chief of the surgical metabolism section, chairman of the gastrointestinal malignancies section, and deputy director of the National Cancer Institute’s (NCI’s) Center for Cancer Research.
Dr. Alexander earned his medical degree from Georgetown University’s School of Medicine located in Washington, DC. He then went on to complete his residency in general surgery at the National Naval Medical Center in Bethesda, Maryland—known today as the Walter Reed National Military Medical Center. Dr. Alexander served on active duty in the U.S. Navy for eight years before pursuing a surgical oncology fellowship at Memorial Sloan Kettering Cancer Center in New York, New York.
Clinical and Laboratory Research
Dr. Alexander’s research and clinical practice focus on the use of innovative surgical techniques aimed at difficult-to-treat cancers, especially advanced cancers that occur in the gastrointestinal tract. While his laboratory research investigates several different types of progressive cancers, Dr. Alexander has a particular interest in malignant peritoneal mesothelioma—a rare cancer type that occurs in the thin cell walls (peritoneum) of the abdominal cavity. Dr. Alexander’s research involves analyzation of mesothelioma tumors at the molecular level—exploring the genes and proteins within tumors in an effort to identify the best treatment approaches for patients with this disease. Dr. Alexander also specializes in the treatment of peritoneal dissemination—the spread of tumors within the abdominal cavity—which he identifies as “a very difficult clinical challenge.” Dr. Alexander believes that the best possible outcomes for patients can be achieved by integrating the strengths of several different treatment modalities for cancer. For example, he often employs a strategy of combined chemotherapy, surgery, and regional intraabdominal chemotherapy in the treatment of his patients which often results in “very significantly improved outcomes.”
A noted lecturer on an international level and published author of more than 250 journal articles, Dr. Alexander is a member of the editorial boards of the Journal of Clinical Oncology and the Annals of Surgical Oncology. He also serves as a reviewer for several prominent scientific publications, including Cancer Research, Annals of Surgery, Surgery, The New England Journal of Medicine, and Clinical Cancer Research. Dr. Alexander is a fellow of the American College of Surgeons, the American Surgical Association, and the Society of Surgical Oncology, as well as a member of several professional organizations, including the Society of University Surgeons, the Association for Academic Surgery, the American Association for Cancer Research, and the American Association of Endocrine Surgeons.
Dr. Alexander’s published articles relative to mesothelioma research and treatment:
National Center for Biotechnology Information, U.S. National Library of Medicine—PubMed.
University of Maryland School of Medicine
University of Maryland Medical Center